Clinical Trial Update: A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting results for brimonidine tartrate 0.15% in patients with primary open-angle glaucoma and ocular hypertension; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Brimonidine Tartrate Ophthalmic Solution 0.15% (brimonidine tartrate)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2014-07-22